KEQU · XBRL financial data

Kewaunee Scientific financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (KEQU's year ends in late April)

In thousands of dollars	Q2 FY24Oct 31, 2023	Q3 FY24Jan 31, 2024	Q4 FY24Apr 30, 2024	Q1 FY25Jul 31, 2024	Q2 FY25Oct 31, 2024	Q3 FY25Jan 31, 2025	Q4 FY25Apr 30, 2025	Q1 FY26Jul 31, 2025	Q2 FY26Oct 31, 2025	Q3 FY26Jan 31, 2026	Q4 FY26Apr 30, 2026	Q1 FY27Jul 31, 2026
Revenue from contracts with customers	50,436	46,778	56,702*	48,393	47,764	67,167	77,148*	71,104	70,096	69,399	71,400*	66,320
Cost of goods and services sold	36,968	34,749	42,062*	35,905	33,812	48,788	53,110*	50,174	50,376	50,854	50,155*	46,681
Gross profit	13,468	12,029	14,640*	12,488	13,952	18,379	24,038*	20,930	19,720	18,545	21,245*	19,639
Research and development	—	—	year only	—	—	—	year only	—	—	—	year only	—
Total operating expenses	8,359	8,223	9,082*	9,913	9,518	16,129	15,538*	16,120	15,613	15,963	16,029*	16,481
Operating income (loss)	5,109	3,806	5,558*	2,575	4,434	2,250	8,500*	4,810	4,107	2,582	5,216*	3,158
Interest expense	372	411	586*	472	442	1,137	1,163*	1,058	1,061	1,112	631*	626
Income tax expense (benefit)	2,015	982	(9,832)*	192	916	(108)	2,202*	761	915	528	1,064*	717
Net income (loss)	2,732	2,521	11,026*	2,193	3,008	1,354	4,850*	3,093	2,445	692	3,388*	1,706
Earnings per share, basic USD per share	0.94	0.87	3.86*	0.77	1.05	0.47	1.70*	1.08	0.85	0.24	1.18*	0.59
Earnings per share, diluted USD per share	0.93	0.85	3.71*	0.74	1.01	0.45	1.63*	1.04	0.82	0.23	1.13*	0.58
Weighted average shares, basic thousands of shares	2,903	2,893	2,860*	2,849	2,872	2,872	2,855*	2,851	2,866	2,866	2,869*	2,880
Weighted average shares, diluted thousands of shares	2,931	2,965	2,972*	2,967	2,974	2,995	2,980*	2,963	2,990	2,983	2,996*	2,921

Balance sheet

CSV

Fiscal quarters (KEQU's year ends in late April)

In thousands of dollars	Q2 FY24Oct 31, 2023	Q3 FY24Jan 31, 2024	Q4 FY24Apr 30, 2024	Q1 FY25Jul 31, 2024	Q2 FY25Oct 31, 2024	Q3 FY25Jan 31, 2025	Q4 FY25Apr 30, 2025	Q1 FY26Jul 31, 2025	Q2 FY26Oct 31, 2025	Q3 FY26Jan 31, 2026	Q4 FY26Apr 30, 2026	Q1 FY27Jul 31, 2026
Cash and cash equivalents	13,722	21,312	23,267	24,211	25,963	9,454	14,942	19,489	12,594	8,153	9,950	8,246
Accounts receivable	42,600	41,109	45,064	43,545	41,885	57,419	62,384	56,897	59,017	54,131	58,738	58,197
Inventory	21,666	21,845	20,679	19,285	18,659	31,560	32,849	34,923	35,499	32,907	30,533	29,786
Prepaid and other current assets	4,899	6,090	5,136	4,683	6,228	7,298	5,966	4,887	5,445	6,193	4,509	5,707
Total current assets	90,876	96,156	96,817	92,699	96,436	108,612	118,363	117,148	113,640	103,578	105,397	103,951
Property and equipment, net	17,834	17,492	17,649	17,112	16,990	23,849	23,174	22,781	23,155	22,610	22,367	21,932
Right-of-use asset	8,393	7,827	7,454	6,944	6,941	13,974	12,965	12,022	11,459	10,449	10,791	10,277
Goodwill	—	—	0	—	—	14,150	12,487	12,487	12,487	12,487	12,487	12,487
Total assets	121,708	126,305	134,766	132,018	134,478	189,148	194,654	193,486	189,075	175,961	178,311	175,800
Accounts payable	19,172	19,083	23,262	20,619	21,458	24,530	27,033	26,327	22,660	23,641	22,455	21,557
Current portion of long-term debt	—	—	—	—	—	3,000	3,000	3,000	3,000	5,000	5,000	5,000
Total current liabilities	38,732	42,142	40,780	36,687	36,471	50,171	53,712	50,486	45,810	48,785	48,351	47,235
Long-term debt	—	—	—	—	—	34,963	34,685	34,380	32,250	16,333	15,083	13,833
Lease liability, non-current	6,193	5,741	5,434	5,111	5,035	9,550	8,797	8,014	7,274	6,496	6,287	5,517
Total liabilities	78,294	80,963	78,557	74,505	73,821	127,027	128,409	124,617	117,358	103,433	101,499	98,580
Retained earnings	33,967	36,488	47,514	49,707	52,715	54,069	58,919	62,012	64,457	65,149	68,537	70,243
Total stockholders' equity	42,108	44,083	54,760	56,023	59,328	60,801	64,457	67,078	69,852	70,675	74,718	75,005
Total liabilities and equity	121,708	126,305	134,766	132,018	134,478	189,148	194,654	193,486	189,075	175,961	178,311	175,800
Common shares outstanding (cover page) thousands of shares	2,902	2,875	2,840	2,872	2,872	2,854	2,844	2,866	2,866	2,866	2,870	2,895

Cash flows

CSV

Fiscal quarters (KEQU's year ends in late April)

In thousands of dollars	Q2 FY24Oct 31, 2023	Q3 FY24Jan 31, 2024	Q4 FY24Apr 30, 2024	Q1 FY25Jul 31, 2024	Q2 FY25Oct 31, 2024	Q3 FY25Jan 31, 2025	Q4 FY25Apr 30, 2025	Q1 FY26Jul 31, 2025	Q2 FY26Oct 31, 2025	Q3 FY26Jan 31, 2026	Q4 FY26Apr 30, 2026	Q1 FY27Jul 31, 2026
Net income (loss)	2,732	2,521	11,026*	2,193	3,008	1,354	4,850*	3,093	2,445	692	3,388*	1,706
Stock-based compensation	241*	241*	363*	318	373*	380*	370*	521	561*	542*	502*	1,899
Depreciation and amortization	—	—	year only	815	806	1,563	1,575*	1,549	1,580	1,597	1,555*	1,591
Net cash from operating activities	747*	9,500*	1,145*	(794)	8,436*	(2,266)*	9,407*	5,791	(4,265)*	11,647*	5,460*	1,976
Net cash from investing activities	(1,265)*	(475)*	(979)*	(278)	(683)*	(29,424)*	(516)*	(771)	(1,570)*	(668)*	(928)*	(772)
Share repurchases	—	—	1,207*	—	—	—	1,596*	0	—	—	year only	529
Proceeds from long-term debt	—	—	year only	—	—	—	—	—	—	—	—	—
Repayments of long-term debt	—	—	year only	—	—	—	—	—	—	—	—	—
Net cash from financing activities	782*	(3,633)*	(1,469)*	343	(3,229)*	14,635*	(4,338)*	(1,463)	(853)*	(14,060)*	(2,950)*	(2,499)
Net change in cash	143*	5,401*	(1,174)*	(752)	4,478*	(17,329)*	4,829*	3,277	(6,762)*	(3,332)*	1,270*	(1,356)

Compare with peers

SIC 3821 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3821 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Kewaunee Scientific	8,246	66,320	1,976	2.9M	—	Q1 FY27 10-QJul 31, 2026
Intest	22,102	35,313	not reported	12.8M	—	Q2 FY26 10-QJun 30, 2026
Geospace Technologies	2,833	15,804	(10,688)*	12.9M	0.3 quarters	Q3 FY26 10-QJun 30, 2026
ScanTech AI Systems	158	631	(758)*	75.6M	0.2 quarters	Q3 FY25 10-QSep 30, 2025
Owlet	30,948	33,865	(92)*	29.2M	336.4 quarters	Q2 FY26 10-QJun 30, 2026
Birchtech	11,836	3,791	(2,790)*	26.3M	4.2 quarters	Q2 FY26 10-QJun 30, 2026
Crawford United	1,923	not reported	5,706*	not reported	—	Q3 FY25 10-QSep 30, 2025
Hurco Companies	52,087	47,289	3,805	6.5M	—	Q3 FY26 10-QJul 31, 2026
Rapid Micro Biosystems	14,687	8,054	(12,702)*	not reported	1.6 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.